Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in rheumatoid arthritis
IRCT20101014004934N2Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: Disease activity, High-sensitivity C-reactive protein and 1 more. Started Nov 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on IRCT20101014004934N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101014004934N2.